Why persistence of Ebola community deaths in Conakry, Guinea? Conakry, January 1st – February 12th 2015 Dominique Jeannel 1,2, Laurel Delayo-Zomahoun 1,

Slides:



Advertisements
Similar presentations
Ebola Facts October 28, /28/14 Identify, Isolate, Inform: ED Evaluation and Management The following diagram provides guidance on evaluation and.
Advertisements

* Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. * EBOLA is a rare but deadly virus.
What is Ebola? 10/12/2014. What is Ebola? Filoviridae Ebolavirus – 5 viruses/species – Ebola (Zaire) – Sudan – Bundibugyo – Tai Forest – Reston Marburgvirus.
E bola Dr Nick Gent. current situation On 23 March 2014, WHO confirmed an outbreak of Ebola virus disease (EVD) in South-eastern Guinea, the first time.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
EVD is a preventable but often fatal viral infection An EVD outbreak is affecting countries in West Africa where disease control resources are very limited.
Transmission The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Human-to-human.
What is Ebola? Ebola is a rare and deadly disease caused by infection with the Ebola virus. It is only spread by direct contact with an infected person's.
Ebola – Facts, Myths, and Fiction Dr M. Oladoyin Odubanjo Executive Secretary, The Nigerian Academy of Science (NAS) 1st Vice Chair, Association of Public.
Ebola Virus. What is Ebola hemorrhagic fever? Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys,
Scale-Free Networks and the Human Ebola Virus By: Hebroon Obaid and Maggie Schramm.
EBOLA OUTBREAK 2014 There has never been an outbreak this size and severity.
PRSENTATION ABOUT EBOLA BY -PARTH MONGA INFORMATION IS BASED UPON VARIOUS RESERCH MATERIALS, I HAVE ONLY COMPOSED IT.FOR THE PURPOSE OF CREATING AWARENESS-PARTH.
The current outbreak of Ebola in west Africa is both a public health emergency of international concern and a human tragedy.
Ebola Virus "Ebola hemorrhagic fever" Created by: Lexington Pittman Michael Trent Jake.
Washington State Ebola Response: From Identify, Isolate and Inform to Frontline, Assessment and Treatment Scott Lindquist MD MPH State Communicable Disease.
INTEGRIS Preparedness Plan: Ebola Virus Disease (EVD) With the spread of Ebola to the U.S., ensuring our employees and communities are safe is the utmost.
INDONESIA PREPAREDNESS AND RESPONSE ON EBOLA VIRUS DISEASE Bangkok, 1 – 3 Desember 2014 Directorat General of Disease Control and Environmental Health.
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
EBOLA Virus Disease August 22, What is Ebola Virus Disease (EVD)? Ebola virus disease (also known as Ebola hemorrhagic fever) is a severe, often-fatal.
Ebola Hemorrhagic Fever Anderson Coates Michael Mastropole.
Network modeling of the Ebola Outbreak Ahmet Aksoy.
Ebola Virus Disease Dr. Oluwafemi Akinyele Popoola Lecturer and Consultant Community Physician Lecture delivered at Bodija-Ashi Baptist Church 14 th September,
Ebola virus  The Ebola virus causes an acute, serious illness which is often fatal if untreated.  The most severely affected countries are: Guinea,
Ebola virus disease. Key facts Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans. The.
Dr. Chaltu Wakijra Oromo Community Organization Washington, D.C April 4, 2015.
EBOLA - ZAIRE. PPE – Personal Protection Equiptment.
Rationale Ebola is a virus that greatly effects not only the human population in various parts of the world, but also in animals such as chimpanzees and.
Clinical Track – Day 1 Located in Murdock. Ebola: Past, Present, Future Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
EBOLA VIRUS FREQUENTLY ASKED QUESTIONS. What is Ebola virus disease? (Formerly Ebola haemorrhagic fever)- a severe, often fatal illness, with a DEATH.
Ebola Virus Disease Clinical manifestations Ebola Virus Disease Clinical manifestations N. Shindo Lead, Clinical & Infection Control Pandemic & Epidemic.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
Ebola Epidemic in Coastal West Africa – Overall Situation Report given at Caritas Internationalis Briefing Meeting 05 November 2014 Dr and Deacon Timothy.
 An acute, severe viral infection  First appeared in 1976 in two simultaneous outbreaks  in a village near the Ebola River in the Democratic Republic.
EBOLA HAEMORRHAGIC FEVER – BLEEDING FEVER 7NEWS EBOLA UPDATE.
As per CDC and WHO, Recent outbreak of Ebola Virus Disease(EVD), New cases and deaths attributable to EVD continue to be reported by the Ministries of.
Investigation and Control of Outbreaks of Foodborne Illness Ralph Cordell, PhD.
Michael Sheer Feb.13, 2008 Ebola Scientific Name: Ebolavirus filoviridae Causative Agent: Ebola Virus Classification: Envelope Glycoprotien Location: The.
SEVERE ACUTE RESPIRATORY SYNDROME – UPDATE Anne-Claire de Benoist and Delia Boccia, European Programme for Intervention.
Training on the Ebola Virus Disease (duration 3 days)
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
Emerging Diseases Lecture 9: Filoviruses 9.1 Overview 9.2: Outbreaks: Marburg, N’zara, Yambuku, Reston, Kikwit, West Africa 9.3 Summary.
Outbreaks and Epidemics Ebola Hemorrhagic Fever. Ebola facts and origins  Ebola hemorrhagic fever is a severe, often-fatal disease in humans and nonhuman.
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) FIELD WORK 2 -Expanded Surveillance Report- -Measles.
The Ebola Outbreak of What is Ebola? It’s a virus It causes EBV (Ebola virus disease) which is a hemorrhagic fever. It affects many organs and blood.
John J. Lanza, MD, PhD, MPH, FAAP Florida Department of Health A Public and Clinical Health Perspective.
Updates on Ebola Virus Disease (EVD) Divina Cabral-Antonio Regional Epidemiology and Surveillance Unit.
Ebola Virus Outbreak, 2014 Dr. Md. Shakeel Waez Asst. Professor (Medicine) Chittagong Medical College.
Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans. The virus is transmitted to people.
Ebola By Jakob Bengtsson and Sturla Slotsvik. Introduction Ebola is a viral disease which affect humans and other primates Ebola is a viral disease which.
Natural History & Spectrum of Diseases
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Ebola Virus Disease: Occupational Safety and Health.
One year ago, there was an Ebola epidemic outbreak scare in Dallas Texas. Today, we have gained great strides to control an epidemic and scientists have.
Ebola Virus BY: HEATHER BRANDSTETTER SAMANTHA LACLAIR JENNA HENSEL DANIELLE GILFUS.
Ebola virus disease - Transmission through body fluids; perspectives from outbreak response in Liberia Dr Margaret Fitzgerald Public Health Medicine.
Information on the Ebola surge in West Africa All you need to know about Ebola (HF) -Jazlyn Selvasingh.
PANDEMIC H1N1 IN HANOI-VIETNAM: OVERVIEW AND RESPONSE.
Patient with Ebola Hemorrhagic Fever, Bumba Zone, Equateur Province, DR Congo (Zaire), October 1976.
The Hot Zone By Richard Preston
DR I.O.LAWAL MBChB(Ife),FWACS(Urol). EBOLA VIRUS DISEASE Introduction Epidemiology Transmission Signs & Symptoms Diagnosis Differentials Treatment/ Health.
Understanding Epidemiology
Ebola Virus and development
Compare the picture of the African Hospital with the British Hospital:
Ebola Virus Disease Dr. Afnan Younis.
Ebola Virus Disease (EVD) WHAT IS IT?
EBOLA VIRUS DISEASE Joseph P. Iser, MD, DrPH, MSc Southern Nevada Health District.
Presentation transcript:

Why persistence of Ebola community deaths in Conakry, Guinea? Conakry, January 1st – February 12th 2015 Dominique Jeannel 1,2, Laurel Delayo-Zomahoun 1, Emmanuel Heleze 1, Mariame Bah-Kante 3, Cyrille G. Diffo 1, André K. Missombo 4, Gaston Tshapenda 4, Geneviève Dennetiere, Lazare Kouassi 1, Karamoko Keita 5, Abdouramane Marega 5, Boubacar Diallo 1, William Perea 1. 1 WHO, Geneva – 2 French Institute for Public Health Surveillance, France – 3 Guinea Presidence Desk – 4 CDC, Atlanta, USA - 5 Health Direction of Conakry City, Guinea Epidemiology and Public Health 2015, Valencai, Spain, August

Ebola fever – Ebola virus Identified in 1976 Filoviridae,  Marbourgvirus  Ebolavirus– 5 viruses  Ebola (Zaire)  Soudan  Bundibugyo  Tai Forest (Ivory Coast)  Reston (animals only) 2

3

Ebola virus disease – key facts The incubation period 2 to 21 days. Humans are not infectious until they develop symptoms. First symptoms are the sudden onset of fever fatigue, muscle pain, headache and sore throat. followed by – vomiting, diarrhoea, rash, – symptoms of impaired kidney and liver function, – in some cases, both internal and external bleeding (e.g. oozing from the gums, blood in the stools). – Laboratory findings include low white blood cell and platelet counts and elevated liver enzymes. Epidemiology and Public Health 2015, Valencai, Spain, August

Ebola worse outbreak Guinea Liberia Sierra Leone cases deaths OMS, 26 janvier – 1er mars 2015, Dominique Jeannel

Context – early February 2015, Conakry, Guinea Although the weekly number of Ebola cases decreased markedly since December 2014 and all Ebola riposte activities were deployed : – the number of Ebola community deaths (ECD) showed no decrease – Conduct safe and dignified burials met with frequent difficulties – reticence/hostility to Ebola control activities were regularly reported A study was then conducted on ECD in Conakry in order to get a better understanding of their circonstances Epidemiology and Public Health 2015, Valencai, Spain, August

Objective Provide accurate information on ECD since 1st January 2015 regarding : – history of contamination and disease, – seeking for health care – social reaction Epidemiology and Public Health 2015, Valencai, Spain, August Conakry city and its 5 communes

Methods Trends analysis during the last 3 months (1st november february 2015) for: – Reported ECD in Conakry (national database) – Ebola reported cases and Ebola deaths in clinics (national database) – Statistics of calls to the Ebola free hotline in Conakry (N°115) For all ECD between 1st January and 12 February 2015, a descriptive analysis was conducted from investigation reports (27 ECD) with collection of the following information – Death classification, type of burial – Transmission chain – Area of residence, place of contamination, place where symptoms started – Patient journey in the community – Patient journey in seeking for health care – Social reaction to control activities Epidemiology and Public Health 2015, Valencai, Spain, August

Trends in confirmed Ebola cases and deaths in Conakry, Guinea week – week Epidemiology and Public Health 2015, Valencai, Spain, August

Number of calls to the free Ebola hotline (N°115) Week to week

Epidemiology and Public Health 2015, Valencai, Spain, August Reasons for calling the free Ebola hotline (N°115) Week to week

Classification of ECD, type of burial Epidemiology and Public Health 2015, Valencai, Spain, August % of ECD were biogically confirmed 59% were reported in Matoto, the largest commune of Conakry city For 74% of ECD, safe and dignified burial was conducted Safe and dignified

Was the deceased previously known as a contact or suspect case? Epidemiology and Public Health 2015, Valencai, Spain, August % of the deceased were not identified as contacts 11% were contacts with no follow-up (No followed-up contact)

Seeking health care For 16 cases (59,3%) seeking medical care was reported 2 deaths occured in a medical clinic (1 private clinic, 1 Donka national hospital) Type of medical structure Number% Private clinic 1244% Public medical center 27% Hospital311% Epidemiology and Public Health 2015, Valencai, Spain, August

Disease duration and reported symptoms Fever 84% Asthenia 90% Diarrhea/vomiting 50% 6 cases of bleeding 2 cases of fœtal death/abortion Epidemiology and Public Health 2015, Valencai, Spain, August

Patients journey Epidemiology and Public Health 2015, Valencai, Spain, August At least 48% attended unsafe funerals At least 59% had contact with an Identified Ebola suspect (mostly identified a posteriori)

Transmission chain Epidemiology and Public Health 2015, Valencai, Spain, August IdentifiedNumber% a posteriori1140 a priori311 imprecise519 unknown726

Social reaction Epidemiology and Public Health 2015, Valencai, Spain, August Hostility 3 physical assaults 1 threat with a weapon 2 death threats

Refusals of control activities For the 27 ACD situations, were reported: 5 refusals of safe and dignified burials and 4 refusals of biological sampling (oral swab) 7 refusals of environmental spraying with bleach 8 refusals of epidemiological investigation 12 refusals of contact follow-up 1 suspect case could not be removed from the family and transfered to an Ebola clinic Epidemiology and Public Health 2015, Valencai, Spain, August

Conclusions (1) ECD in Conakry early 2015 originated mainly from contamination while helping an Ebola patient or during funeral attendance in places of active transmission in low Guinea Most of Ebola community deaths in Conakry concerned individuals not identified as contacts For three quaters, biological sampling could performed and safe and dignified burial conducted When the information was available, most of the deceased has sought medical care at least once, mosly in private clinics – 2 patients deceased in a medical clinic/hospital – 6 cases presented with bleeding Problem of triage in medical facilities, private as well as public Epidemiology and Public Health 2015, Valencai, Spain, August

Conclusion (2) Transmission chain: identified a postériori for the majority of Conakry ECD For the majority of ECD: – Residence in Conakry – Ebola symptoms started in Conakry – At least one third got contaminated in Conakry and 40 % elsewhere (area with Ebola active transmission in low Guinea) – The origin of the contamination chain was mostly outside Conakry Epidemiology and Public Health 2015, Valencai, Spain, August

Conclusion In more than half of the ECD situations, cooperation of the family was obtained But open hostility (family and/or neighbours) occured one out of four ECD situations The majority of hostile reactions or reluctances were reported in Matoto commune Principal consequences of social difficulties – Refusals of environmental spraying – Refusals of epidemiologic investigations – Refusals of contact follow-up Epidemiology and Public Health 2015, Valencai, Spain, August

Impact of the study on the improvemnt of Ebola strategy in Guinea The study brought useful information to: Implement active surveillance Implement more efficient triage methods in all clinics and hospitals as well as prevention of infection for health workers The cas definition was modified in march, to improve its sensitivity and help physicians to identified suspect cases and call for intervention of field epidemiologists for case classification Epidemiology and Public Health 2015, Valencai, Spain, August

Many thanks to All the field epidemiologic teams in Conakry that have been working very hard to investigate cases and ECD, collect epidemiological data, supervize contact follow-up, and provide information and confort to the population All the wonderfull colleagues involved in the fight against Ebola epidemics Epidemiology and Public Health 2015, Valencai, Spain, August Matoto team, Conakry